AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34836079 — intervention group
Group type: EXPERIMENTAL
Intervention: EXCO (exercise + 2 g/day oil from Calanus finmarchicus)
Number of subjects: 0
Study 34836079 — intervention group
Group type: COMPARATOR
Intervention: CON (control group, no treatment)
Number of subjects: 0
Study 32203595 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation
Number of subjects: 40
Study 32203595 — intervention group
Group type: COMPARATOR
Intervention: Augmented surgery
Number of subjects: 40
Study 34102553 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-based intervention under nurse guidance including home BP monitoring, medication reminders, and education on hypertension delivered weekly for 12 months.
Number of subjects: 500
Study 34102553 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-based intervention under nurse guidance.
Number of subjects: 500
Study 34102553 — intervention group
Group type: COMPARATOR
Intervention: Usual care as determined by local guidelines.
Number of subjects: 500
Study 33109273 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention for 6 months
Number of subjects: 88
Study 33109273 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 88
Study 33109273 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 88
Study 35217670 — intervention group
Group type: COMPARATOR
Intervention: albendazole
Number of subjects: 80
Study 35217670 — intervention group
Group type: EXPERIMENTAL
Intervention: albendazole and ivermectin combination therapy
Number of subjects: 80
Study 34847060 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week mobile device-based resilience training program
Number of subjects: 103
Study 34847060 — intervention group
Group type: COMPARATOR
Intervention: Control group (8-week program of placebo information)
Number of subjects: 103
Study 34903116 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated milk (F-milk) adjunctive to 1000-ppm fluoride dentifrice (FD)
Number of subjects: 7
Study 34903116 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fluoridated milk (non-F-milk) adjunctive to 1000-ppm fluoride dentifrice (FD)
Number of subjects: 7
Study 34903116 — intervention group
Group type: COMPARATOR
Intervention: 1000-ppm fluoride dentifrice (FD) alone
Number of subjects: 7
Study 32597390 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) intervention; patient-selected relaxing 3D videos projected during TAVI
Number of subjects: 32
Study 36103212 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosing grape seed flour (GSF ≈ 1 g/kg)
Number of subjects: 30
Study 36103212 — intervention group
Group type: COMPARATOR
Intervention: Starch (placebo)
Number of subjects: 30
Study 34088883 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE of 9, 1, 4, or 8 minutes
Number of subjects: 20
Study 34088883 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE of 13, 1, 4, or 8 minutes
Number of subjects: 20
Study 34088883 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE of 17, 1, 4, or 8 minutes
Number of subjects: 20
Study 34088883 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased RPEs (9, 13, 17)
Number of subjects: 20
Study 32428066 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary intervention with motivational approach
Number of subjects: 37
Study 32428066 — intervention group
Group type: COMPARATOR
Intervention: Control - traditional approach aiming at lifestyle modifications
Number of subjects: 37
Study 34575371 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30
Study 34575371 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 32432319 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental variable (IV) analysis using bed availability in the intensive care unit as an instrument for admission to the intensive care unit.
Number of subjects: 0
Study 32432319 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of IV balance or bias with the balance or bias that would have been produced under randomization.
Number of subjects: 0
Study 35916524 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-Tazobactam (TZP)
Number of subjects: 40
Study 35916524 — intervention group
Group type: COMPARATOR
Intervention: Carbapenems
Number of subjects: 40
Study 34256159 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher level of caregiver mastery
Number of subjects: 170
Study 32232481 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim PET (i-PET) with ΔSUV ≥66%
Number of subjects: 158
Study 32232481 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔSUV as a continuous variable
Number of subjects: 158
Study 32232481 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual 5-point scale (5-PS) on i-PET
Number of subjects: 158
Study 32232481 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔSUV ≥66%
Number of subjects: 158
Study 35356064 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 152
Study 33720783 — intervention group
Group type: EXPERIMENTAL
Intervention: ViperaTAb antivenom
Number of subjects: 170
Study 35610532 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term methimazole (LT‐MMI)
Number of subjects: 64
Study 35610532 — intervention group
Group type: COMPARATOR
Intervention: Radioactive iodine (RAI)
Number of subjects: 64
Study 32959604 — intervention group
Group type: EXPERIMENTAL
Intervention: TB treatment under BRAC program
Number of subjects: 900
Study 33547300 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus standard care
Number of subjects: 26
Study 33023492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (17 facilities)
Number of subjects: 3400
Study 33023492 — intervention group
Group type: COMPARATOR
Intervention: Control group (24 facilities)
Number of subjects: 3400
Study 35637847 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) in groups B and C
Number of subjects: 184
Study 35637847 — intervention group
Group type: COMPARATOR
Intervention: Control group D (no Dex)
Number of subjects: 184
Study 33096207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling strategies with pools of 5, 10, 20, or 50 samples
Number of subjects: 150
Study 32212418 — intervention group
Group type: EXPERIMENTAL
Intervention: IV relebactam 1150 mg
Number of subjects: 0
Study 32212418 — intervention group
Group type: COMPARATOR
Intervention: Oral moxifloxacin 400 mg (positive control)
Number of subjects: 0
Study 32212418 — intervention group
Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 0
Study 34823416 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ Kids programme (FT, n = 12)
Number of subjects: 24
Study 33611898 — intervention group
Group type: EXPERIMENTAL
Intervention: Firesorb bioresorbable scaffold (BRS) implantation
Number of subjects: 45
Study 32554183 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) administration
Number of subjects: 20
Study 32554183 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 20
Study 32554183 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (no intervention)
Number of subjects: 20
Study 32846465 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label RCTs
Number of subjects: 110
Study 32846465 — intervention group
Group type: COMPARATOR
Intervention: Blinded RCTs
Number of subjects: 110
Study 33561904 — intervention group
Group type: COMPARATOR
Intervention: Control virgin olive oil (VOO)
Number of subjects: 33
Study 33561904 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin olive oil enriched with its own phenolic compounds (FVOO)
Number of subjects: 33
Study 33561904 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin olive oil enriched with additional phenolic compounds from thyme (FVOOT)
Number of subjects: 33
Study 32581088 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (4×375 mg/m2) and glucocorticoids (higher or lower dose regimen, reducing from either 1 mg/kg/day or 0.5 mg/kg/day to 10 mg/day by 4 months)
Number of subjects: 188
Study 35340062 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab every 6 months
Number of subjects: 110
Study 35340062 — intervention group
Group type: COMPARATOR
Intervention: Risedronate daily
Number of subjects: 110
Study 34309006 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous EEG (cEEG)
Number of subjects: 364
Study 34309006 — intervention group
Group type: COMPARATOR
Intervention: Repeated routine EEG (rEEG)
Number of subjects: 364
Study 32052026 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifenthrin barrier spray and larval habitat management (LHM)
Number of subjects: 16
Study 32052026 — intervention group
Group type: EXPERIMENTAL
Intervention: Larval habitat management (LHM) alone
Number of subjects: 16
Study 32052026 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifenthrin barrier spray alone
Number of subjects: 16
Study 32052026 — intervention group
Group type: COMPARATOR
Intervention: Yards neighboring treated yards
Number of subjects: 16
Study 34037578 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of medicinal plants at home
Number of subjects: 376
Study 34037578 — intervention group
Group type: COMPARATOR
Intervention: Use of traditional remedies for fever control
Number of subjects: 376
Study 34037578 — intervention group
Group type: COMPARATOR
Intervention: Use of traditional remedies for common cold management
Number of subjects: 376
Study 34037578 — intervention group
Group type: COMPARATOR
Intervention: Following traditional care during a common cold
Number of subjects: 376
Study 34037578 — intervention group
Group type: COMPARATOR
Intervention: Growing medicinal plants at home
Number of subjects: 376
Study 34037578 — intervention group
Group type: COMPARATOR
Intervention: Using medicinal plants for health purposes in the household
Number of subjects: 376
Study 35763097 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard prophylactic intravenous hydration
Number of subjects: 0
Study 35763097 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 33283757 — intervention group
Group type: EXPERIMENTAL
Intervention: RDI ≥30 episodes/h
Number of subjects: 265
Study 33283757 — intervention group
Group type: COMPARATOR
Intervention: RDI <30 episodes/h
Number of subjects: 265
Study 32506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic erythropoietin (10,000 units twice a day for 3 days)
Number of subjects: 0
Study 32506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids (prednisone 75 mg daily tapered off in 6 weeks)
Number of subjects: 0
Study 32506278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 32506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic erythropoietin
Number of subjects: 0
Study 32506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids
Number of subjects: 0
Study 32506278 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin matrix (PRFM)
Number of subjects: 15
Study 35172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood mesenchymal stem cells (PBMSCs) embedded in PRFM
Number of subjects: 15
Study 35172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin matrix (PRFM) with PBMSCs
Number of subjects: 15
Study 34109595 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with NSCLC and COVID-19
Number of subjects: 342
Study 34109595 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR >8.35
Number of subjects: 342
Study 34109595 — intervention group
Group type: EXPERIMENTAL
Intervention: PLR >29.14
Number of subjects: 342
Study 34109595 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR and PLR
Number of subjects: 342
Study 34109595 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls without COVID-19
Number of subjects: 342
Study 33003591 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min thermotherapy
Number of subjects: 0
Study 33003591 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-min thermotherapy
Number of subjects: 0
Study 33003591 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36050629 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided internal superior laryngeal nerve block with 2 ml of 0.25% ropivacaine bilaterally immediately after operation
Number of subjects: 0
Study 36050629 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 36050629 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (US-guided iSLN block)
Number of subjects: 0
Study 34182375 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional wine
Number of subjects: 44
Study 34182375 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural wine
Number of subjects: 44
Study 34182375 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled group (dealcoholized wine)
Number of subjects: 44
Study 34182375 — intervention group
Group type: COMPARATOR
Intervention: Control group (BAC = 0 g/l)
Number of subjects: 44
Study 35497374 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital COPD education program (accessible for three months)
Number of subjects: 37
Study 35497374 — intervention group
Group type: COMPARATOR
Intervention: Control group (no digital COPD education program)
Number of subjects: 37
Study 32556658 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional endodontic access
Number of subjects: 20
Study 32556658 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive endodontic access
Number of subjects: 20
Study 32666428 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade approach (AGA)
Number of subjects: 217
Study 32666428 — intervention group
Group type: COMPARATOR
Intervention: Retrograde approach (RGA)
Number of subjects: 217
Study 33582875 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Pilot View (SPV)
Number of subjects: 34
Study 33582875 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 34
Study 34213683 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP (15 cm H2O) with FBS
Number of subjects: 72
Study 34213683 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP (15 cm H2O) with DW
Number of subjects: 72
Study 34213683 — intervention group
Group type: COMPARATOR
Intervention: Control (0 cm H2O)
Number of subjects: 72
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: High CaCO3 content
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: Low groundwater table levels
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: High shrub cover
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: Groundwater table level, canopy cover, and proportion of damaged trees
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: Deer browsing
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: Soil properties (pH, CaCO3 content)
Number of subjects: 32
Study 32889266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ash dieback
Number of subjects: 32
Study 33318373 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-kHz High-frequency Therapy (HF10 Therapy)
Number of subjects: 0
Study 33318373 — intervention group
Group type: COMPARATOR
Intervention: Traditional low-frequency SCS
Number of subjects: 0
Study 35298314 — intervention group
Group type: EXPERIMENTAL
Intervention: PA + anodal tDCS
Number of subjects: 28
Study 35298314 — intervention group
Group type: COMPARATOR
Intervention: PA + sham tDCS
Number of subjects: 28
Study 32885341 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP followed by laser therapy of the periodontal pockets with 980 nm diode laser, 1 W, continuous wave mode, 20 s per tooth side, repeated twice at 5–7 day intervals.
Number of subjects: 36
Study 32885341 — intervention group
Group type: COMPARATOR
Intervention: SRP (scaling, root planing and polishing)
Number of subjects: 36
Study 32960886 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching (TBHC)
Number of subjects: 4283
Study 32960886 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 4283
Study 36129713 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVE (6-week automated interactive text message program)
Number of subjects: 218
Study 36129713 — intervention group
Group type: COMPARATOR
Intervention: Control (attention control group)
Number of subjects: 218
Study 34105614 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial myofunctional therapy associated with photobiomodulation
Number of subjects: 11
Study 34105614 — intervention group
Group type: COMPARATOR
Intervention: Orofacial myofunctional therapy associated with inactive photobiomodulation (placebo)
Number of subjects: 11
Study 33082420 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic oxygenated machine perfusion (HOPE)
Number of subjects: 15
Study 33082420 — intervention group
Group type: COMPARATOR
Intervention: Conventional-cold-storage (CCS)
Number of subjects: 15
Study 33082420 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE
Number of subjects: 15
Study 33082420 — intervention group
Group type: COMPARATOR
Intervention: CCS
Number of subjects: 15
Study 35954510 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 22
Study 35954510 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 22
Study 35954510 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study 33653805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose prenatal vitamin D3 supplementation
Number of subjects: 1176
Study 33653805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1176
Study 33075157 — intervention group
Group type: EXPERIMENTAL
Intervention: FamTechCare telehealth intervention
Number of subjects: 68
Study 33075157 — intervention group
Group type: COMPARATOR
Intervention: Standard telephone support
Number of subjects: 68
Study 32239190 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide-timolol
Number of subjects: 63
Study 32239190 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 63
Study 35843287 — intervention group
Group type: COMPARATOR
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE (Arm A)
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE + 2 L of polyethylene glycol (PEG) 12 hours before CE (Arm B)
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE + 1 L PEG + sodium ascorbate 3 hours before CE (Arm C)
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall SBVQ across the 3 arms
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal SBVQ across the 3 arms
Number of subjects: 229
Study 35843287 — intervention group
Group type: COMPARATOR
Intervention: Tolerability in Arm A
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerability in Arm B
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerability in Arm C
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of tolerability between Arm A and Arms B and C
Number of subjects: 229
Study 32618857 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe lift under the nonaffected leg with balance training (shoe insert group, n = 18)
Number of subjects: 36
Study 32618857 — intervention group
Group type: COMPARATOR
Intervention: Balance training alone (control group, n = 18)
Number of subjects: 36
Study 32113756 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium propionate supplementation (5% dry matter)
Number of subjects: 24
Study 33006767 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroid (TCS) - mometasone furoate 0.1% ointment + dummy NB‐UVB
Number of subjects: 517
Study 33006767 — intervention group
Group type: COMPARATOR
Intervention: Narrowband UVB (NB‐UVB) - NB‐UVB + placebo TCS
Number of subjects: 517
Study 33006767 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment - TCS + NB‐UVB
Number of subjects: 517
Study 32213509 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (20 sessions at true acupuncture points plus usual care)
Number of subjects: 150
Study 32213509 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (20 sessions at heterosegmental non-acupuncture points plus usual care)
Number of subjects: 150
Study 36311789 — intervention group
Group type: EXPERIMENTAL
Intervention: ECM‐associated mRNA‐lncRNA‐based prognostic panel (ECM‐APP)
Number of subjects: 0
Study 36311789 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 2 (best prognosis)
Number of subjects: 0
Study 36311789 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk population (unfavorable prognosis)
Number of subjects: 0
Study 36311789 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk population (favorable prognosis)
Number of subjects: 0
Study 34401368 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy for insomnia (iCBT-i)
Number of subjects: 21
Study 34401368 — intervention group
Group type: COMPARATOR
Intervention: active control group
Number of subjects: 21
Study 32858844 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intake for 4 weeks
Number of subjects: 61
Study 32858844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 36028858 — intervention group
Group type: EXPERIMENTAL
Intervention: Givosiran (2.5 mg/kg monthly)
Number of subjects: 94
Study 36028858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 33252870 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 1154
Study 33252870 — intervention group
Group type: COMPARATOR
Intervention: Face-mask ventilation
Number of subjects: 1154
Study 36167599 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix (240-80-80 mg) + Apalutamide (240 mg/d) for 3 months
Number of subjects: 89